ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #8,382Hybrid

European Journal of Cancer Prevention

Acronym:ejcp
•
Abbreviation (ISO):EUR J CANCER PREV
•
Identifier (ISSN):0959-8278(Print)/1473-5709(Online)
•
Publisher:Lippincott Williams and Wilkins Ltd.
Clarivate IF (2026)
2.5– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for European Journal of Cancer Prevention

WoS Q3
12342.8920182.3320192.4120202.520212.1620222.420232.120242.520252.52026
Annual Impact Factor Metric
Current (2026):2.5
Scopus SJR & RankScopus Q2
0.691
#8,382

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
93

93 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate4.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
64articles/year
20.41% Gold OA•87.01% Original Research

Aims & Scope

European Journal of Cancer Prevention aims to promote an increased awareness of all aspects of cancer prevention and to stimulate new ideas and innovations. The Journal has a wide-ranging scope, covering such aspects as descriptive and metabolic epidemiology, histopathology, genetics, biochemistry, molecular biology, microbiology, clinical medicine, intervention trials and public education, basic laboratory studies and special group studies. Although affiliated to a European organization, the journal addresses issues of international importance.

Topics Covered (Recognized by AI)
Medicine94.5%Biology86.7%Internal medicine85.1%Genetics78.9%Cancer67.7%Pathology55.6%Chemistry43.4%Mathematics37.5%Biochemistry36.9%Environmental health33.9%Sociology31.9%Demography30.5%Statistics30%Oncology26.4%Physics24.5%Population23.6%Endocrinology21.2%Surgery20.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q3
Rank204/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank206/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.5
Articles / Year34
Total Citations6
2025
IF2.5
Articles / Year56
Total Citations106
2024
IF2.1
Articles / Year79
Total Citations334
2023
IF2.4
Articles / Year95
Total Citations703
2022
IF2.164
Articles / Year44
Total Citations375

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,382Scopus Q2SCImago Profile
Scopus Coverage:1991-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.691

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.56

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,100 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations529
3-Year Documents226
Citable Documents209

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EpidemiologyQ2
Public Health, Environmental and Occupational HealthQ2
Cancer ResearchQ3
OncologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

European Journal of Cancer Prevention (acronym: ejcp, abbr: EUR J CANCER PREV, ISSN: 0959-8278) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1991. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.691 (Q2), an H-index of 93.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 64 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,100 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1991
Indexing & Databases
SCIEScopusPubMed
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 025686a0-7c5d-4ec3-a97a-780148b3bed7
Database Updated: 2026-09-28